Skip to main content
Premium Trial:

Request an Annual Quote

John West, John Stuelpnagel, Tristan Orpin, Christian Henry, Matt Posard, Omead Ostadan, Blaine Bowman, Roy Whitfield

Premium
Illumina has made several management changes in the wake of its acquisition of Solexa last month. John West, the former CEO of Solexa, has joined Illumina as senior vice president and general manager of the sequencing business; John Stuelpnagel, Illumina’s COO, will now also serve as general manager of the company’s microarray business; Tristan Orpin, Illumina’s vice president of sales, has been promoted to senior vice president in charge of all commercial operations; Christian Henry, vice president and CFO, has been promoted to senior vice president and CFO and has assumed the additional responsibility of investor relations; Matt Posard, vice president of marketing, is now vice president of sales; while Omead Ostadan, formerly vice president of marketing at Solexa, will replace Posard as vice president of marketing at Illumina. In addition, Solexa directors Blaine Bowman and Roy Whitfield have joined Illumina’s board.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.